FibroGen Announces Chinese State FDA Approval of Phase 1 and 2 Development of ... - PharmaLive.com (press release) Print
PharmaLive.com (press release)In addition, at that time there was a limited health insurance system in China, so provision of care for ESRD patients, including dialysis and anemia

... read more